Sandy Spring Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sandy Spring Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.62M	Sell	32,357 -549	-2%	-$49.1K	0.11%	152
2024 Q4	$2.96M	Sell	32,906 -1,103	-3%	-$107K	0.12%	140
2024 Q3	$3.36M	Buy	34,009 +1,727	+5%	+$170K	0.14%	133
2024 Q2	$2.99M	Buy	32,282 +429	+1%	+$38.5K	0.13%	137
2024 Q1	$3.02M	Buy	31,853 +8,643	+37%	+$802K	0.14%	133
2023 Q4	$2.07M	Sell	23,210 -2,596	-10%	-$193K	0.1%	155
2023 Q3	$1.88M	Sell	25,806 -2,407	-9%	-$192K	0.1%	159
2023 Q2	$2.35M	Sell	28,213 -2,124	-7%	-$178K	0.13%	142
2023 Q1	$2.31M	Sell	30,337 -1,693	-5%	-$140K	0.13%	146
2022 Q4	$2.66M	Sell	32,030 -2,860	-8%	-$232K	0.16%	136
2022 Q3	$2.77M	Sell	34,890 -296	-0.8%	-$25K	0.18%	125
2022 Q2	$2.61M	Sell	35,186 -1,226	-3%	-$92K	0.16%	129
2022 Q1	$3.27M	Sell	36,412 -4,868	-12%	-$450K	0.17%	121
2021 Q4	$4.62M	Buy	41,280 +133	+0.3%	+$16K	0.22%	105
2021 Q3	$5.17M	Buy	41,147 +997	+2%	+$128K	0.27%	91
2021 Q2	$5.44M	Buy	40,150 +3,264	+9%	+$429K	0.29%	88
2021 Q1	$5M	Sell	36,886 -619	-2%	-$92.7K	0.29%	89
2020 Q4	$5.28M	Sell	37,505 -495	-1%	-$63.4K	0.32%	78
2020 Q3	$4.23M	Sell	38,000 -1,573	-4%	-$176K	0.29%	88
2020 Q2	$4.43M	Sell	39,573 -4,757	-11%	-$469K	0.33%	76
2020 Q1	$3.43M	Sell	44,330 -3,486	-7%	-$309K	0.31%	83
2019 Q4	$4.55M	Sell	47,816 -5,573	-10%	-$482K	0.33%	77
2019 Q3	$4.07M	Sell	53,389 -1,620	-3%	-$135K	0.32%	79
2019 Q2	$4.83M	Buy	55,009 +4,525	+9%	+$386K	0.39%	70
2019 Q1	$4.57M	Buy	50,484 +6,470	+15%	+$550K	0.39%	71
2018 Q4	$3.16M	Buy	44,014 +8,410	+24%	+$678K	0.3%	87
2018 Q3	$3.41M	Buy	35,604 +1,700	+5%	+$165K	0.28%	96
2018 Q2	$3.23M	Buy	33,904 +4,921	+17%	+$452K	0.28%	93
2018 Q1	$2.54M	Buy	28,983 +760	+3%	+$69.4K	0.23%	123
2017 Q4	$2.4M	Sell	28,223 -140	-0.5%	-$11.7K	0.22%	124
2017 Q3	$2.46M	Sell	28,363 -1,400	-5%	-$112K	0.24%	120
2017 Q2	$2.3M	Sell	29,763 -490	-2%	-$34.8K	0.23%	122
2017 Q1	$2.1M	Sell	30,253 -1,999	-6%	-$134K	0.21%	135
2016 Q4	$1.91M	Sell	32,252 -175	-0.5%	-$10.8K	0.2%	140
2016 Q3	$2.15M	Sell	32,427 -290	-0.9%	-$17.9K	0.23%	120
2016 Q2	$1.77M	Buy	32,717 +800	+3%	+$43.8K	0.2%	133
2016 Q1	$1.65M	Buy	31,917 +1,900	+6%	+$98.7K	0.19%	140
2015 Q4	$2.11M	Buy	30,017 +3,051	+11%	+$208K	0.25%	106
2015 Q3	$1.68M	Buy	26,966 +1,820	+7%	+$143K	0.21%	124
2015 Q2	$2.11M	Sell	25,146 -75	-0.3%	-$5.83K	0.24%	108
2015 Q1	$1.9M	Buy	25,221 +108	+0.4%	+$7.54K	0.22%	123
2014 Q4	$1.56M	Buy	25,113 +18	+0.1%	+$1.03K	0.19%	135
2014 Q3	$1.3M	Buy	25,095 +315	+1%	+$16.1K	0.16%	144
2014 Q2	$1.27M	Buy	24,780 +1,680	+7%	+$75.7K	0.16%	144
2014 Q1	$1.1M	Hold	23,100	–	–	0.17%	150
2013 Q4	$1M	Hold	23,100	–	–	0.14%	149
2013 Q3	$995K	Sell	23,100 -300	-1%	-$12.2K	0.15%	145
2013 Q2	$813K	Buy	+23,400	New	+$822K	0.13%	157

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Sandy Spring Bank's XBI Position: Q1 2025 in Review

Sandy Spring Bank reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.7% in Q1 2025, selling an estimated $49.1K and leaving 32,357 shares worth $2.62M. The position accounts for 0.11% of the portfolio, ranked #152.

Sandy Spring Bank first reported a position in XBI in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.44M in Q2 2021. 683 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Sandy Spring Bank held 32,357 shares of State Street SPDR S&P Biotech ETF worth $2.62M as of Q1 2025.
Sandy Spring Bank sold 549 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $49.1K.
State Street SPDR S&P Biotech ETF made up 0.11% of Sandy Spring Bank's portfolio in Q1 2025, its #152 holding.
Sandy Spring Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 48 quarters since.
Sandy Spring Bank's State Street SPDR S&P Biotech ETF position peaked at $5.44M in Q2 2021.
683 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.